Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the effects of rosuvastatin compared to usual care in patients diagnosed with aortic valvular stenosis. Patients must have a diagnosis of mild to moderate aortic...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
Collaborators
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07469371 · Severe Aortic Stenosis
NCT07278310 · Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
NCT06777368 · Aortic Stenosis
Research site
Calgary, Alberta
Research site
Edmonton, Alberta
Research site
Surrey, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions